Schedule 13D ownership disclosure

GALECTO INC

Common Stock, par value $0.00001 per share · CUSIP: 36322Q107

Event date: 2025-09-23

Filing-level shares
86,579.00
Percent of class
6.5%
  • Novo Holdings A/SReported CIK 0001388325

    Shares: 86,579.00 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001388325-25-000004
Form type
SCHEDULE 13D/A
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Sep 25, 2025
Reporting period
Sep 23, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub